# Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other Comorbities

> **NCT01975480** · PHASE4 · COMPLETED · sponsor: **START Clinic for Mood and Anxiety Disorders** · enrollment: 29 (actual)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **DRUG:** Desvenlafaxine

## Key facts

- **NCT ID:** NCT01975480
- **Lead sponsor:** START Clinic for Mood and Anxiety Disorders
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2020-04-15
- **Final completion:** 2020-05-01
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2020-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01975480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01975480, "Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other Comorbities". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01975480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*